Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.58 Billion USD | 14.97% |
| 2022 | 2.25 Billion USD | 9.87% |
| 2021 | 2.04 Billion USD | 9.39% |
| 2020 | 1.87 Billion USD | 63.87% |
| 2019 | 1.14 Billion USD | 23.06% |
| 2018 | 928.74 Million USD | 13.71% |
| 2017 | 816.74 Million USD | 78.86% |
| 2016 | 456.64 Million USD | 65.98% |
| 2015 | 275.12 Million USD | -8.95% |
| 2014 | 302.15 Million USD | 4.93% |
| 2013 | 287.95 Million USD | 45.39% |
| 2012 | 198.05 Million USD | -5.5% |
| 2011 | 209.58 Million USD | 34.15% |
| 2010 | 156.23 Million USD | -8.98% |
| 2009 | 171.64 Million USD | 57.15% |
| 2008 | 109.22 Million USD | -16.45% |
| 2007 | 130.74 Million USD | 128.81% |
| 2006 | 57.14 Million USD | 240.28% |
| 2005 | 16.79 Million USD | -38.08% |
| 2004 | 27.12 Million USD | 447.01% |
| 2003 | 4.95 Million USD | -71.69% |
| 2002 | 17.51 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.88 Billion USD | 9.82% |
| 2024 Q1 | 2.62 Billion USD | 1.38% |
| 2023 Q4 | 2.58 Billion USD | 4.88% |
| 2023 Q1 | 2.28 Billion USD | 1.69% |
| 2023 Q2 | 2.38 Billion USD | 4.22% |
| 2023 FY | 2.58 Billion USD | 14.97% |
| 2023 Q3 | 2.46 Billion USD | 3.43% |
| 2022 Q4 | 2.25 Billion USD | 3.92% |
| 2022 FY | 2.25 Billion USD | 9.87% |
| 2022 Q3 | 2.16 Billion USD | 2.48% |
| 2022 Q1 | 2.06 Billion USD | 1.0% |
| 2022 Q2 | 2.11 Billion USD | 2.15% |
| 2021 Q4 | 2.04 Billion USD | 2.5% |
| 2021 Q2 | 1.92 Billion USD | 4.54% |
| 2021 Q1 | 1.84 Billion USD | -1.75% |
| 2021 FY | 2.04 Billion USD | 9.39% |
| 2021 Q3 | 1.99 Billion USD | 3.91% |
| 2020 Q1 | 1.1 Billion USD | -3.04% |
| 2020 Q3 | 1.71 Billion USD | 5.16% |
| 2020 Q4 | 1.87 Billion USD | 9.49% |
| 2020 Q2 | 1.62 Billion USD | 46.79% |
| 2020 FY | 1.87 Billion USD | 63.87% |
| 2019 Q4 | 1.14 Billion USD | -9.89% |
| 2019 Q2 | 977.72 Million USD | 2.64% |
| 2019 Q3 | 1.26 Billion USD | 29.73% |
| 2019 Q1 | 952.61 Million USD | 2.57% |
| 2019 FY | 1.14 Billion USD | 23.06% |
| 2018 FY | 928.74 Million USD | 13.71% |
| 2018 Q4 | 928.74 Million USD | 4.79% |
| 2018 Q1 | 829.76 Million USD | 1.59% |
| 2018 Q2 | 838.85 Million USD | 1.1% |
| 2018 Q3 | 886.3 Million USD | 5.66% |
| 2017 FY | 816.74 Million USD | 78.86% |
| 2017 Q4 | 816.74 Million USD | 63.24% |
| 2017 Q3 | 500.34 Million USD | 8.93% |
| 2017 Q2 | 459.32 Million USD | 3.23% |
| 2017 Q1 | 444.95 Million USD | -2.56% |
| 2016 Q2 | 263.04 Million USD | 3.25% |
| 2016 Q4 | 456.64 Million USD | 0.76% |
| 2016 FY | 456.64 Million USD | 65.98% |
| 2016 Q1 | 254.77 Million USD | -7.4% |
| 2016 Q3 | 453.19 Million USD | 72.29% |
| 2015 Q4 | 275.12 Million USD | -6.14% |
| 2015 Q2 | 300.39 Million USD | -1.74% |
| 2015 FY | 275.12 Million USD | -8.95% |
| 2015 Q3 | 293.12 Million USD | -2.42% |
| 2015 Q1 | 305.71 Million USD | 1.18% |
| 2014 Q4 | 302.15 Million USD | 0.32% |
| 2014 FY | 302.15 Million USD | 4.93% |
| 2014 Q1 | 288.52 Million USD | 0.2% |
| 2014 Q2 | 325.32 Million USD | 12.75% |
| 2014 Q3 | 301.19 Million USD | -7.42% |
| 2013 Q1 | 280.89 Million USD | 41.83% |
| 2013 Q4 | 287.95 Million USD | -0.53% |
| 2013 Q3 | 289.49 Million USD | 1.17% |
| 2013 Q2 | 286.15 Million USD | 1.87% |
| 2013 FY | 287.95 Million USD | 45.39% |
| 2012 FY | 198.05 Million USD | -5.5% |
| 2012 Q1 | 203.94 Million USD | -2.69% |
| 2012 Q4 | 198.05 Million USD | 3.35% |
| 2012 Q3 | 191.64 Million USD | -0.16% |
| 2012 Q2 | 191.94 Million USD | -5.89% |
| 2011 Q4 | 209.58 Million USD | -2.87% |
| 2011 FY | 209.58 Million USD | 34.15% |
| 2011 Q3 | 215.78 Million USD | -4.6% |
| 2011 Q2 | 226.19 Million USD | 51.88% |
| 2011 Q1 | 148.92 Million USD | -4.68% |
| 2010 FY | 156.23 Million USD | -8.98% |
| 2010 Q1 | 159.03 Million USD | -7.35% |
| 2010 Q2 | 161.99 Million USD | 1.86% |
| 2010 Q3 | 149.85 Million USD | -7.49% |
| 2010 Q4 | 156.23 Million USD | 4.26% |
| 2009 Q1 | 119.85 Million USD | 9.73% |
| 2009 Q4 | 171.64 Million USD | 46.55% |
| 2009 Q3 | 117.12 Million USD | 17.94% |
| 2009 Q2 | 99.31 Million USD | -17.14% |
| 2009 FY | 171.64 Million USD | 57.15% |
| 2008 Q4 | 109.22 Million USD | -19.29% |
| 2008 Q2 | 154.57 Million USD | 32.72% |
| 2008 FY | 109.22 Million USD | -16.45% |
| 2008 Q1 | 116.46 Million USD | -10.92% |
| 2008 Q3 | 135.33 Million USD | -12.45% |
| 2007 Q1 | 47.68 Million USD | -16.55% |
| 2007 Q2 | 149.14 Million USD | 212.78% |
| 2007 Q3 | 135.6 Million USD | -9.08% |
| 2007 Q4 | 130.74 Million USD | -3.59% |
| 2007 FY | 130.74 Million USD | 128.81% |
| 2006 Q4 | 57.14 Million USD | 27.24% |
| 2006 Q3 | 44.9 Million USD | 0.0% |
| 2006 FY | 57.14 Million USD | 240.28% |
| 2005 FY | 16.79 Million USD | -38.08% |
| 2005 Q4 | 16.79 Million USD | 0.0% |
| 2004 FY | 27.12 Million USD | 447.01% |
| 2003 FY | 4.95 Million USD | -71.69% |
| 2002 FY | 17.51 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -8151.61% |
| BrainsWay Ltd. | 62.97 Million USD | -4010.081% |
| Cerus Corporation | 197.74 Million USD | -1208.838% |
| Envoy Medical, Inc. | 7.64 Million USD | -33776.963% |
| electroCore, Inc. | 16.38 Million USD | -15694.227% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -33547.946% |
| IceCure Medical Ltd | 16.41 Million USD | -15672.09% |
| Inogen, Inc. | 326.19 Million USD | -693.454% |
| OrthoPediatrics Corp. | 449.58 Million USD | -475.685% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -9391.016% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -15511.307% |
| MaxCyte, Inc. | 268.27 Million USD | -864.76% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -31863.686% |
| Nexalin Technology, Inc. | 3.63 Million USD | -71162.661% |
| Orthofix Medical Inc. | 925.31 Million USD | -179.71% |
| PAVmed Inc | 33.11 Million USD | -7714.849% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -1704.227% |
| RxSight, Inc. | 182.55 Million USD | -1317.803% |
| Sight Sciences, Inc. | 166.65 Million USD | -1453.066% |
| SI-BONE, Inc. | 230.42 Million USD | -1023.229% |
| TELA Bio, Inc. | 78.04 Million USD | -3216.164% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -927.443% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -24021.156% |
| Acutus Medical, Inc. | 53.96 Million USD | -4696.516% |
| Talis Biomedical Corporation | 98.34 Million USD | -2531.889% |
| Spectral AI, Inc. | 10.69 Million USD | -24106.884% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -1083.729% |
| CVRx, Inc. | 115.22 Million USD | -2146.136% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -4312.131% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -82981.535% |
| Bioventus Inc. | 810.91 Million USD | -219.172% |
| Venus Concept Inc. | 93.65 Million USD | -2663.577% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -9961.03% |
| LivaNova PLC | 2.42 Billion USD | -6.529% |
| 908 Devices Inc. | 202.98 Million USD | -1175.095% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -221.432% |
| Nemaura Medical Inc. | 14.56 Million USD | -17672.153% |
| NeuroPace, Inc. | 107.65 Million USD | -2304.251% |
| LENSAR, Inc. | 69.58 Million USD | -3619.48% |
| Apyx Medical Corporation | 79.24 Million USD | -3166.28% |
| Cutera, Inc. | 346.29 Million USD | -647.406% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -6060.034% |
| BioSig Technologies, Inc. | 1.79 Million USD | -143848.832% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -856.354% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -5966.9% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 31.565% |
| Axonics, Inc. | 719.92 Million USD | -259.511% |
| Outset Medical, Inc. | 313.8 Million USD | -724.79% |
| IRIDEX Corporation | 34.43 Million USD | -7415.972% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -539.509% |
| IRadimed Corporation | 92.15 Million USD | -2708.496% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -49161.515% |
| INVO Bioscience, Inc. | 20.88 Million USD | -12290.973% |
| Telesis Bio, Inc. | 70.41 Million USD | -3575.846% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -1579.531% |
| Varex Imaging Corporation | 1.24 Billion USD | -107.122% |
| Quipt Home Medical Corp. | 247.4 Million USD | -946.126% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -27700.215% |
| Pulmonx Corporation | 178.95 Million USD | -1346.318% |
| Dynatronics Corporation | 25.94 Million USD | -9877.426% |
| Modular Medical, Inc. | 13.8 Million USD | -18645.564% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -24027.902% |
| Semler Scientific, Inc. | 78.06 Million USD | -3215.442% |
| InMode Ltd. | 863.28 Million USD | -199.808% |
| Bruker Corporation | 4.24 Billion USD | 39.1% |
| Cytosorbents Corporation | 53.26 Million USD | -4759.499% |
| DexCom, Inc. | 6.26 Billion USD | 58.685% |
| Align Technology, Inc. | 6.08 Billion USD | 57.458% |
| Viveve Medical, Inc. | 25.91 Million USD | -9888.037% |
| ZimVie Inc. | 1.2 Billion USD | -114.727% |
| Movano Inc. | 9.42 Million USD | -27372.667% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -420.065% |
| Nexalin Technology, Inc. | 3.63 Million USD | -71162.661% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -4312.131% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -171.682% |
| Profound Medical Corp. | 43.68 Million USD | -5824.507% |
| enVVeno Medical Corporation | 48.63 Million USD | -5221.682% |
| Surmodics, Inc. | 185.73 Million USD | -1293.506% |
| iCAD, Inc. | 41.41 Million USD | -6148.974% |
| Nuwellis, Inc. | 9.77 Million USD | -26391.3% |
| Biotricity, Inc. | 5.94 Million USD | -43453.144% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -497.538% |
| Aethlon Medical, Inc. | 8.24 Million USD | -31287.408% |
| InspireMD, Inc. | 47.64 Million USD | -5332.487% |
| PAVmed Inc. | 33.11 Million USD | -7714.849% |
| BIOLASE, Inc. | 35.1 Million USD | -7273.579% |
| Beyond Air, Inc. | 56.96 Million USD | -4443.811% |
| FONAR Corporation | 214.24 Million USD | -1108.051% |
| AxoGen, Inc. | 196.82 Million USD | -1214.962% |
| Vivani Medical, Inc. | 45.79 Million USD | -5551.462% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -819.634% |
| Inari Medical, Inc. | 674.23 Million USD | -283.872% |
| UFP Technologies, Inc. | 404.13 Million USD | -540.428% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -10961.364% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -27135.286% |
| Tenon Medical, Inc. | 6.34 Million USD | -40691.174% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -27413.554% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -2397.112% |
| AdaptHealth Corp. | 4.61 Billion USD | 43.976% |
| Sintx Technologies, Inc. | 15.36 Million USD | -16744.777% |
| NanoVibronix, Inc. | 6.67 Million USD | -38680.342% |
| Quanterix Corporation | 425.01 Million USD | -508.972% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -27700.215% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -4717.317% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -48.235% |
| TransMedics Group, Inc. | 706.04 Million USD | -266.576% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -3995.772% |
| NeuroMetrix, Inc. | 21.42 Million USD | -11980.595% |
| Hyperfine, Inc. | 94.19 Million USD | -2647.588% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -863.442% |
| Biomerica, Inc. | 9.25 Million USD | -27868.446% |
| Bone Biologics Corporation | 3.73 Million USD | -69144.626% |
| AVITA Medical, Inc. | 144.33 Million USD | -1693.127% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -53061.826% |
| Silk Road Medical, Inc | 265.3 Million USD | -875.542% |